| Histological subtypes of the oesophagus | Adenocarcinoma in sub sites of the stomach | ||||||||||
| Squamous cell carcinoma | Adenocarcinoma | Cardia | Distant stomach | NOS | |||||||
| Cases/person time at risk (years) | RR† (95% CI) | Cases/person time at risk (years) | RR‡ (95% CI) | Cases/person time at risk (years) | RR‡ (95% CI) | Cases/person time at risk (years) | RR§ (95% CI) | Cases/person time at risk (years) | RR†† (95% CI) | ||
| Height at baseline (cm) | |||||||||||
| M: <170 | 20/6441 | 1.0 (Referent) | 19/7306 | 1.0 (Referent) | 13/7306 | 1.0 (Referent) | 37/7237 | 1.0 (Referent) | 28/7237 | 1.0 (Referent) | |
| F: <160 | |||||||||||
| M: 170–174 | 15/11210 | 0.41 (0.20 to 0.82) | 37/12151 | 1.15 (0.65 to 2.04) | 37/12151 | 1.64 (0.86 to 3.13) | 71/12075 | 1.18 (0.78 to 1.78) | 42/12075 | 0.85 (0.51 to 1.40) | |
| F: 160–164 | |||||||||||
| M: 175–179 | 29/14110 | 0.67 (0.36 to 1.23) | 36/15248 | 0.98 (0.55 to 1.73) | 44/15248 | 1.71 (0.90 to 3.23) | 73/15064 | 1.06 (0.70 to 1.60) | 49/15064 | 0.91 (0.55 to 1.50) | |
| F: 165–169 | |||||||||||
| M: 180–184 | 17/8234 | 0.57 (0.27 to 1.20) | 21/9076 | 0.88 (0.46 to 1.67) | 34/9076 | 2.01 (1.05 to 3.86) | 42/8988 | 0.94 (0.59 to 1.50) | 32/8988 | 0.89 (0.52 to 1.51) | |
| F: 170–174 | |||||||||||
| M: ⩾185 | 5/4255 | 0.37 (0.13 to 1.08) | 11/4540 | 0.86 (0.40 to 1.85) | 17/4540 | 1.85 (0.88 to 3.92) | 12/4529 | 0.54 (0.27 to 1.08) | 22/4529 | 1.30 (0.71 to 2.39) | |
| F: ⩾175 | |||||||||||
| p trend¶ = 0.22 | p trend = 0.40 | p trend = 0.06 | p trend = 0.07 | p trend = 0.52 | |||||||
| Continuous, 5 cm increments | 86/44249 | 0.90 (0.74 to 1.11) | 124/48321 | 0.95 (0.83 to 1.08) | 145/48321 | 1.07 (0.95 to 1.21) | 235/47893 | 0.92 (0.83 to 1.01) | 173/47893 | 1.03 (0.90 to 1.18) | |
*RR, rate ratio; CI, confidence interval; NOS, adenocarcinoma of the stomach, not otherwise specified; M, males; F, females. The first year of follow-up was excluded from the analyses. Case-cohort analyses were used, which means that the cases were identified from the entire cohort, while the person years were based only on the subcohort.
†Rate ratios adjusted for age; sex; BMI at baseline (kg/m2); current smoking (yes/no); number of cigarettes/day; and number of years of smoking; alcohol intake (g/day); and fruit consumption (g/day).
‡Rate ratios adjusted for age; sex; BMI at baseline (kg/m2); current smoking (yes/no); number of cigarettes/day; and number of years of smoking.
§Rate ratio adjusted for age; sex; BMI at baseline (kg/m2); current smoking (yes/no); number of cigarettes/day; number of years of smoking; and highest level of education (primary school, lower vocational school, high school and higher vocational/university).
††Rate ratio adjusted for age; sex; BMI at baseline (kg/m2); current smoking (yes/no); number of cigarettes/day; number of years of smoking; highest level of education (primary school, lower vocational school, high school and higher vocational/university); and a history of gastric ulcer or bleeding (yes/no).
¶Tests for dose-respond trends were assessed by fitting ordinal variables as continuous terms in the Cox proportional hazard model. p Trends were calculated for all categories of a variable. The reported p values are two sided.